Attention-deficit/hyperactivity disorder: Current aspects on pharmacogenetics

Pharmacogenomics Journal

Volumn 3, Issue 1, 2003, Pages 11-13

  Rohde, Luis Augusto ^a   Roman, T ^a,b   Hutz, M H ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE; PROTEIN DAT1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRAIN BLOOD FLOW; DOPAMINE RELEASE; DRUG MECHANISM; DRUG RESPONSE; FRONTAL LOBE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; MOLECULAR GENETICS; PHARMACOGENETICS; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DNA-BINDING PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; NERVE TISSUE PROTEINS; PHARMACOGENETICS; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 0037248441     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500158     Document Type: Article

References (18)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994, pp. 78-85.
2. Rohde LA, Biederman J, Busnello EA, Zimmermann H, Schmitz M, Martins S et al. ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions and impairments. J Am Acad Child Adolesc Psychiatry 1999; 38: 716-722.
3. Smalley SL. Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit/hyperactivity disorder. Am J Hum Genet 1997; 60: 1276-1282.
4. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S et al. Dopamine genes and ADHD. Neurosci Biobehav Rev 2000; 24: 21-25.
5. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the dopamine D4 gene 7-repeated allele and attention-deficit/hyperactive disorder. Am J Psychiatry 2001; 158: 1052-1057.
6. American Academy of Pediatrics. Clinical Practice Guideline: Treatment of school age children with ADHD. Pediatrics 2001; 108: 1033-1044.
7. Winsberg BG, Comings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry 1999; 38: 1474-1477.
8. Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz MH. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 2002; 12: 497-499.
9. Seeman P, Mandras BK. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 1998; 3: 386-396.
10. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001; 1: 152-156.
11. Rhode LA, Roman T, Szobot C, Cunha RD, Hutz M, Biederman J. Dopamine Transporter Gene, Response to Methylphenidate and Cerebial Blood Flow in Attention-Deficit/Hyperactivity Disorder. A Pilot Study Synapse (in press).
12. Volkow N, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 2002; 43: 181-187.
13. Kirley A, Hawi Z, Daly G, Gill M. Dopamine transporter gene and response to methylphenidate. Presented in the 3rd Annual Meeting of the ADHD Molecular Genetics Network, Dublin, May 2002.
14. Stein MA, Sarampote C, Waldman I, Seymour K, Robb A, Colon C et al. Dopamine transporter genotype affects stimulants response according to parent ratings. Presented in the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, October 2002.
15. Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention-deficit/hyperactivity disorder. Genet Epidemiol 2000; 18: 1-16.
16. Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 1993; 2: 767-773.
17. Hamarman S. ADHD children with DRD4 7-repeat allele require higher stimulant doses. Presented in the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, October 2002.
18. Seeger G, Schloss P, Schmidt MH. Marker gene polymorphisms in hyperkinetic disorder - predictors of clinical response to treatment with methylphenidate? Neurosci Lett 2001; 313: 45-48.